Home7AY1 • FRA
add
Actinium Pharmaceuticals Inc
Previous close
€1.12
Day range
€1.10 - €1.10
Year range
€1.00 - €9.80
Market cap
40.87M USD
Avg Volume
376.00
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.50M | -28.00% |
Net income | -6.65M | 28.66% |
Net profit margin | — | — |
Earnings per share | -0.21 | 36.36% |
EBITDA | -7.45M | 27.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 72.90M | -4.92% |
Total assets | 76.90M | -5.58% |
Total liabilities | 44.14M | -2.05% |
Total equity | 32.76M | — |
Shares outstanding | 31.20M | — |
Price to book | 1.06 | — |
Return on assets | -23.60% | — |
Return on capital | -50.54% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.65M | 28.66% |
Cash from operations | -5.75M | 23.22% |
Cash from investing | 0.00 | — |
Cash from financing | -3.00K | -100.25% |
Net change in cash | -5.75M | 8.64% |
Free cash flow | -3.65M | 18.89% |
About
CEO
Founded
2000
Website
Employees
37
